Marshall Wace
LENZ

Marshall Wace’s LENZ Therapeutics LENZ Stock Holding History

Marshall Wace’s Portfolio LENZ Stock Details LENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.8M Buy
493,099
+332,835
+208% +$2.68M ﹤0.01% 1659
2026
Q1 		$1.47M Buy
160,264
+125,012
+355% +$1.76M ﹤0.01% 1953
2025
Q4 		$564K Buy
+35,252
New +$1.03M ﹤0.01% 2190
2024
Q3 		– Sell
-22,554
Closed -$390K – 3031
2024
Q2 		$390K Buy
+22,554
New +$394K ﹤0.01% 2054
2023
Q2 		– Sell
-5,844
Closed -$100K – 3043
2023
Q1 		$100K Buy
+5,844
New +$94.5K ﹤0.01% 2499
2022
Q3 		– Sell
-7,235
Closed -$139K – 3877
2022
Q2 		$139K Buy
+7,235
New +$161K ﹤0.01% 3232

Other funds holding LENZ

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
AWG
Alpha Wave Global New York $6.24B AUM 59.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
7IH
72 Investment Holdings Stamford, Connecticut $50M AUM 647.58% 1-Year Est. Return

Marshall Wace's LENZ Position: Q2 2026 in Review

Marshall Wace increased its LENZ Therapeutics (LENZ) stake by 208% in Q2 2026, buying an estimated $2.68M and bringing the position to 493,099 shares worth $2.8M. The position accounts for ﹤0.01% of the portfolio, ranked #1659.

Marshall Wace first reported a position in LENZ in Q2 2022 and has held it in 6 quarters since. 144 funds tracked by Wall St. Rank hold LENZ as of Q2 2026.

  • Marshall Wace held 493,099 shares of LENZ Therapeutics worth $2.8M as of Q2 2026.
  • Marshall Wace bought 332,835 LENZ Therapeutics shares in Q2 2026, an estimated $2.68M.
  • LENZ Therapeutics made up ﹤0.01% of Marshall Wace's portfolio in Q2 2026, its #1659 holding.
  • Marshall Wace first reported a position in LENZ Therapeutics in Q2 2022 and has held it in 6 quarters since.
  • 144 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.